FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

391817003: Bendrofluazide - chemical (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1465997013 Bendrofluazide - chemical (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1485811019 Bendrofluazide - chemical en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2536615011 Bendroflumethiazide - chemical en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1465997013 Bendrofluazide - chemical (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1465997013 Bendrofluazide - chemical (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1485811019 Bendrofluazide - chemical en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1485811019 Bendrofluazide - chemical en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2536615011 Bendroflumethiazide - chemical en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2536615011 Bendroflumethiazide - chemical en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Bendrofluazide - chemical Is a Diuretic (substance) false Inferred relationship Existential restriction modifier (core metadata concept)

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Bendroflumethiazide 2.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bendrofluazide - chemical Inferred relationship Existential restriction modifier (core metadata concept)
    Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bendrofluazide - chemical Inferred relationship Existential restriction modifier (core metadata concept)
    Bendrofluazide+potassium 2.5mg/8.4mmol m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bendrofluazide - chemical Inferred relationship Existential restriction modifier (core metadata concept)
    Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bendrofluazide - chemical Inferred relationship Existential restriction modifier (core metadata concept)
    Bendroflumethiazide 5 mg and nadolol 80 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bendrofluazide - chemical Inferred relationship Existential restriction modifier (core metadata concept)
    Bendroflumethiazide 2.5 mg and timolol maleate 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bendrofluazide - chemical Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bendrofluazide - chemical Inferred relationship Existential restriction modifier (core metadata concept)
    Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bendrofluazide - chemical Inferred relationship Existential restriction modifier (core metadata concept)
    Bendroflumethiazide + nadolol 5mg/40mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bendrofluazide - chemical Inferred relationship Existential restriction modifier (core metadata concept)
    Bendroflumethiazide + nadolol 5mg/80mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bendrofluazide - chemical Inferred relationship Existential restriction modifier (core metadata concept)
    Propranolol hydrochloride + bendrofluazide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bendrofluazide - chemical Inferred relationship Existential restriction modifier (core metadata concept)

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    SAME AS association reference set (foundation metadata concept)

    Back to Start